IQVIA AI Clinical Decision Support Tools (CDST)此为应为文档

FactSheetQVIA

IQVIAAIClinicalDecisionSupportTools(CDST)

NovelwayforLifeSciencestopartnerwithprovidersabove-brandtoidentifyandcloseclinicalcaregaps

Gapsincare,suchasdelayindiagnosis,deferreddiagnosticmonitoring,under-treatment,andmedicationnon-

adherencearewidespreadacrosstherapeuticareas.Theyimpedeoptimalproductadoption,increasehealthcarecosts,andultimatelyresultinworsepatientoutcomes.Caregapsaredrivenbyfactorssuchasprovidershortages,competingclinicalpriorities,limitedprovidertimewithpatients,andslowadoptionofemergingcomplexclinicalguidelines.

Effectivelyaddressingthesecaregapscanimprovebothappropriateproductuseandpatientoutcomes.

30%

ofpatientsnever

diagnosedwithdisease

SalesVolume

30%ofpatientsdiagnosedtoolatefortreatment

20%

ofpatientsuntreated

ofpatients

non-adherent

5%

15%

ofpatientsreceive

treatmentandarecured

Year

ProductLaunchEndofProductLifecycle

IdealSalesVolumethroughoutproductlifecycle

ActualSalesVolumethroughoutproductlifecycle

Lifesciencecompaniescanplayanimportantroleinovercomingthesecaregapsbydevelopingabove-brandclinicaldecisionsupporttools.Thesetoolsanalyzecomplexhealthcaredatatoenhanceproviders’abilitytogettheright

patienttotherighttreatmentattherighttime.

ThefoundationalanalyticsengineoftheCDSTcanidentifythesecaregapsbasedonlow-complexityclinicalguidelinesoradvancedAIalgorithms,surfacingpatientrisksotherwiseoverlookedincommonpracticeenvironments.NaturalLanguageProcessingcanbeusedtosurfacekeyunstructureddatarelevanttoapatient’sclinicaltrajectorysuchas

healthequitychallenges,SocialDeterminantsofHealth,familyhistory,andpatient-reportedoutcomes.EachCDSTisintegratedintuitivelyintotheclinicalworkflowandispackagedwithaplaybooktosupportadoption.

IQVIAprovidesend-to-endsupportwiththedesign,development,anddeploymentofCDSTprogramsatscale,bringingmulti-disciplinaryexpertisetoeachengagement,speedinguptimetopatientidentificationand

appropriatetreatment.

LifecycleofaClinicalDecisionSupportToolDevelopment

DEVEL0P

analyticsto

surfacecaregaps

DEPL0Y

intoroutineclinicalcare

DEFINE

caregapstobeaddressedinCDST

INTEGRATE

intuitivelyintoEMRandclinicalworkflow

SMART-on-FHIRapplicationaccessibleintheEMR

IQVIAbringsmulti-disciplinaryexpertisetosupportend-to-enddevelopmentanddeploymentofaCDSTprograms

•AccesstoIQVIAcuratedhealthcare

dataaroundtheglobeforover20years

•Validatedstandardsforsecuredatastorage,processingandQC

•RegulatoryexpertiseforSaMDclassificationandCDST

Data

exemption

Regulatory

•RobustComplianceframework,TransferofValuereporting

Analytics

•DiverseHCOintegrationmethods(ex.flatfile,SMART-on-FHIRapp)

•PartnershipswithindividualHCOs&DataAggregators

Governance

•AwardwinningAIandNLP

methodologiesvalidatedon200+studiesover20years

•CustomSoftwareToolkitforETL,AIalgorithmdevelopmentandscalableautomateddeployment

HCO

Integration

Clinical

•SpecialistMDswithdeepclinicalknowledge

•Informaticiansforclinicalworkflowintegrationforprovideradoption

•Clinicalcapacityfordirectpatientoutreach*

*Maturityoftheofferingtoprovideclinicalcapacityvariesbygeography

IQVIAhasbeendevelopingClinicalDecisionSupporttoolsincollaborationwithdifferenthealthcarestakeholders(governments,providers,non-profits,andlifesciences),acrossawidevarietyofclinicalareasandgeographies.

SurfacinghiddenSDoHrisk

factorsfor56%morepatients

toprioritizeengagementof

SupportingCDC’sAntibiotics

Stewardshipprogramby

developingacustomapp

forflaggingdriversof

inappropriateprescribing

socialworkers

Predictingriskofstroke

leadingto22%reduction

instrokeincidence

©2024AllrightsreservedIQVIA®isaregisteredtrademarkofIQVIAInc.intheUnitedStates,theEuropeanUnion,andvariousothercountries.04.2024.USCAN.BCS2024-0792-03MAR

followingtherapyreview

andadjustment

IQVIA’sawardwinningAI&NLP

methodologiesvalidatedon

200+diseasesforover20+years

“ThiswasanexcellentreviewtoidentifypatientswhocanbenefitfromDOACs,butalsooptimisepatientcarethusreducingmorbidityandpossibleassociatedmortality.HelpedstreamlinetheprescribingprocessesforthepracticewithabenefitofachievingmaximumpointsforAtrialFibrillation.”

-PrimaryCareProviderandEnduseroftheCDSTforriskforstroke

Takeaways

•Buildeffectiveabove-brandpartnershipswithproviderstoidentifyandclosecaregap